Baker Biotech Capital (GP), LLC Insider Trading $PCYC PHARMACYCLICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Biotech Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital (GP), LLC. Baker Biotech Capital (GP), LLC is 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM).
Baker Biotech Capital (GP), LLC in PHARMACYCLICS INC
Trading Symbol: PCYCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 557,211 shares
Latest Transaction: Feb 14 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Biotech Capital (GP), LLC in PHARMACYCLICS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, GHDX, TZYM, PCYC, SGEN, GEVA, VPHM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 14 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 20.85 | 150,000 | 3,128,040 | 557,211 | 407.2 K to 557.2 K (+36.84 %) |
Jan 26 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.89 | 12,907 | 230,942 | 407,211 | 394.3 K to 407.2 K (+3.27 %) |
Jan 26 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.95 | 28,966 | 519,960 | 394,304 | 365.3 K to 394.3 K (+7.93 %) |
Jan 26 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.43 | 3,018 | 55,629 | 365,338 | 362.3 K to 365.3 K (+0.83 %) |
Jan 26 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.55 | 18,547 | 343,997 | 362,320 | 343.8 K to 362.3 K (+5.40 %) |
Jan 26 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.01 | 14,629 | 263,424 | 343,773 | 329.1 K to 343.8 K (+4.44 %) |
Jan 26 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.86 | 7,926 | 141,534 | 329,144 | 321.2 K to 329.1 K (+2.47 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Option Exercise | X | 15.00 | 16 | 240 | 0 | |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Option Exercise | X | 15.00 | 28 | 420 | 16 | |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Option Exercise | P | 15.00 | 16 | 240 | 44 | |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Option Exercise | P | 15.00 | 28 | 420 | 28 | |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 16.84 | 7,925 | 133,456 | 321,218 | 313.3 K to 321.2 K (+2.53 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 16.88 | 12,694 | 214,254 | 313,293 | 300.6 K to 313.3 K (+4.22 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 16.90 | 7,590 | 128,252 | 300,599 | 293 K to 300.6 K (+2.59 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | X | 15.00 | 1,600 | 24,000 | 293,009 | 291.4 K to 293 K (+0.55 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | X | 15.00 | 2,800 | 42,000 | 291,409 | 288.6 K to 291.4 K (+0.97 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 16.44 | 12,041 | 197,940 | 288,609 | 276.6 K to 288.6 K (+4.35 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 16.41 | 31,115 | 510,585 | 276,568 | 245.5 K to 276.6 K (+12.68 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 15.81 | 426 | 6,735 | 245,453 | 245 K to 245.5 K (+0.17 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 16.07 | 1,795 | 28,843 | 245,027 | 243.2 K to 245 K (+0.74 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 16.07 | 3,839 | 61,686 | 243,232 | 239.4 K to 243.2 K (+1.60 %) |
Dec 06 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 15.42 | 11,694 | 180,358 | 239,393 | 227.7 K to 239.4 K (+5.14 %) |
Dec 06 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 15.39 | 2,867 | 44,110 | 227,699 | 224.8 K to 227.7 K (+1.28 %) |
Nov 30 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 14.92 | 11,164 | 166,590 | 224,832 | 213.7 K to 224.8 K (+5.22 %) |
Nov 30 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 14.26 | 11,544 | 164,598 | 213,668 | 202.1 K to 213.7 K (+5.71 %) |
Nov 30 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 14.12 | 16,327 | 230,500 | 202,124 | 185.8 K to 202.1 K (+8.79 %) |
Nov 30 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 13.38 | 8,858 | 118,506 | 185,797 | 176.9 K to 185.8 K (+5.01 %) |
Nov 30 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 13.32 | 16,906 | 225,196 | 176,939 | 160 K to 176.9 K (+10.56 %) |
Nov 23 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 12.76 | 3,141 | 40,079 | 160,033 | 156.9 K to 160 K (+2.00 %) |
Nov 23 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 12.87 | 2,138 | 27,508 | 156,892 | 154.8 K to 156.9 K (+1.38 %) |
Nov 23 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 12.51 | 642 | 8,030 | 154,754 | 154.1 K to 154.8 K (+0.42 %) |
Nov 23 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 12.01 | 1,103 | 13,252 | 154,112 | 153 K to 154.1 K (+0.72 %) |
Nov 23 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 12.25 | 327 | 4,007 | 153,009 | 152.7 K to 153 K (+0.21 %) |
Oct 04 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 11.62 | 60,000 | 696,960 | 152,682 | 92.7 K to 152.7 K (+64.74 %) |
Oct 04 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 11.54 | 25,000 | 288,553 | 92,682 | 67.7 K to 92.7 K (+36.94 %) |
Oct 04 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 11.79 | 12,317 | 145,184 | 67,682 | 55.4 K to 67.7 K (+22.25 %) |
Oct 04 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 11.79 | 13,846 | 163,236 | 55,365 | 41.5 K to 55.4 K (+33.35 %) |
Page: 1